The voluntary suspension confirms the results are at least good and able to go forward for FDA approval.
If the results were not good enough it would have been a straight out declaration that further refinement is required, get hit big time and move on.
As there is a prolonged halt to trading it has got to mean that in light of the results there are moves afoot to either consider contract offers, or apply to be in the FDA fast track approval pilot study or both.
The voluntary suspension confirms the results are at least good...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #